Showing results (981-990 of 1,031) with videos related to
Sort By:
Pageof 104
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs?Elizabeth A Richey, E Alison Lyons, Jonathan R Nebeker, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 15, 2013
Functional genetic variation in NFKBIA and susceptibility to childhood asthma, bronchiolitis, and bronchopulmonary dysplasiaSalman Ali, Aaron F Hirschfeld, Matthew L Mayer, et al.Biological Psychiatry|September 11, 2007
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phasesMartin B Keller, Madhukar H Trivedi, Michael E Thase, et al.Heart, Lung & Circulation|May 31, 2021
Impact of COVID-19 on Diagnostic Cardiac Procedural Volume in Oceania: The IAEA Non-Invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)Patricia O'Sullivan, John Younger, Niels Van Pelt, et al.American Journal of Public Health|August 26, 2021
Best Practices for Conducting Clinical Trials With Indigenous Children in the United StatesJennifer L Shaw, Erin Semmens, May Okihiro, et al.Biological Psychiatry|October 11, 2003
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depressionAlan J Gelenberg, Madhukar H Trivedi, A John Rush, et al.The Journal of Clinical Psychiatry|August 10, 2007
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT StudyJames H Kocsis, Michael E Thase, Madhukar H Trivedi, et al.Human Pathology|December 18, 2020
The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration studyWillem Jan van Weelden, Casper Reijnen, Heidi V N Küsters-Vandevelde, et al.Plos One|May 2, 2015
Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy modelsSethu Sankaranarayanan, Donna M Barten, Laurel Vana, et al.The Journal of Clinical Psychiatry|September 15, 2007
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phasesMartin B Keller, Madhukar H Trivedi, Michael E Thase, et al.Pageof 104